Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Wilson

Showing results (161-170 of 237) with videos related to

Pageof 24
Sort By:
Journal of Substance Abuse Treatment|March 26, 2022
Non-prescribed buprenorphine preceding treatment intake and clinical outcomes for opioid use disorderArthur Robin Williams, Christine M Mauro, Tianshu Feng, et al.
Advances in Therapy|November 22, 2024
Efanesoctocog Alfa Versus Emicizumab in Adolescent and Adult Patients With Haemophilia A Without InhibitorsMaría Teresa Álvarez Román, Nana Kragh, Patricia Guyot, et al.
Advances in Therapy|November 22, 2024
Efanesoctocog Alfa versus Standard and Extended Half-Life Factor VIII Prophylaxis in Adolescent and Adult Patients with Haemophilia A without InhibitorsRobert Klamroth, Nana Kragh, Alix Arnaud, et al.
The Journal of Biological Chemistry|December 16, 2004
Col1a1 promoter-targeted expression of p20 CCAAT enhancer-binding protein beta (C/EBPbeta), a truncated C/EBPbeta isoform, causes osteopenia in transgenic miceJohn R Harrison, Yu-Feng Huang, K Amanda Wilson, et al.
BMJ (Clinical Research Ed.)|December 4, 2003
Using socioeconomic evidence in clinical practice guidelinesRosemary Aldrich, Lynn Kemp, Jenny Stewart Williams, et al.
Infectious Diseases and Therapy|January 10, 2026
Evaluating the Effectiveness of 2024-2025 Seasonal mRNA-1273 Vaccination Against COVID-19-Related Hospitalizations and Medically Attended COVID-19 Among Adults Aged ≥ 18 years in the United States: An Observational Matched Cohort StudyNevena Vicic, Alina Bogdanov, Zhe Zheng, et al.
Infectious Diseases and Therapy|June 24, 2026
Interim Effectiveness of 2025-2026 mRNA-1283 and BNT162b2 COVID-19 Vaccines Against COVID-19-Related Outcomes Among Adults Aged ≥ 65 Years in the United StatesNevena Vicic, Alina Bogdanov, Heather Hensler, et al.
Annals of Hematology|May 12, 2020
Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH RegistryHubert Schrezenmeier, Alexander Röth, David J Araten, et al.
The American Journal of Managed Care|November 1, 2017
Implementing an oncology precision medicine clinic in a large community health systemMichael A Thompson, Jennifer J Godden, Scott M Weissman, et al.
Journal of Intensive Care Medicine|July 21, 2022
Malignant Catatonia: A Review for the IntensivistJennifer Connell, Mark Oldham, Pratik Pandharipande, et al.
Pageof 24

Showing results (161-170 of 237) with videos related to

Sort By:
Pageof 24
Journal of Substance Abuse Treatment|March 26, 2022
Non-prescribed buprenorphine preceding treatment intake and clinical outcomes for opioid use disorderArthur Robin Williams, Christine M Mauro, Tianshu Feng, et al.
Advances in Therapy|November 22, 2024
Efanesoctocog Alfa Versus Emicizumab in Adolescent and Adult Patients With Haemophilia A Without InhibitorsMaría Teresa Álvarez Román, Nana Kragh, Patricia Guyot, et al.
Advances in Therapy|November 22, 2024
Efanesoctocog Alfa versus Standard and Extended Half-Life Factor VIII Prophylaxis in Adolescent and Adult Patients with Haemophilia A without InhibitorsRobert Klamroth, Nana Kragh, Alix Arnaud, et al.
The Journal of Biological Chemistry|December 16, 2004
Col1a1 promoter-targeted expression of p20 CCAAT enhancer-binding protein beta (C/EBPbeta), a truncated C/EBPbeta isoform, causes osteopenia in transgenic miceJohn R Harrison, Yu-Feng Huang, K Amanda Wilson, et al.
BMJ (Clinical Research Ed.)|December 4, 2003
Using socioeconomic evidence in clinical practice guidelinesRosemary Aldrich, Lynn Kemp, Jenny Stewart Williams, et al.
Infectious Diseases and Therapy|January 10, 2026
Evaluating the Effectiveness of 2024-2025 Seasonal mRNA-1273 Vaccination Against COVID-19-Related Hospitalizations and Medically Attended COVID-19 Among Adults Aged ≥ 18 years in the United States: An Observational Matched Cohort StudyNevena Vicic, Alina Bogdanov, Zhe Zheng, et al.
Infectious Diseases and Therapy|June 24, 2026
Interim Effectiveness of 2025-2026 mRNA-1283 and BNT162b2 COVID-19 Vaccines Against COVID-19-Related Outcomes Among Adults Aged ≥ 65 Years in the United StatesNevena Vicic, Alina Bogdanov, Heather Hensler, et al.
Annals of Hematology|May 12, 2020
Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH RegistryHubert Schrezenmeier, Alexander Röth, David J Araten, et al.
The American Journal of Managed Care|November 1, 2017
Implementing an oncology precision medicine clinic in a large community health systemMichael A Thompson, Jennifer J Godden, Scott M Weissman, et al.
Journal of Intensive Care Medicine|July 21, 2022
Malignant Catatonia: A Review for the IntensivistJennifer Connell, Mark Oldham, Pratik Pandharipande, et al.
Pageof 24